Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ackerman, Michael J  [Clear All Filters]
2023
Clemens DJ, Ye D, Wang L, Kim CSJohn, Zhou W, Dotzler SM, Tester DJ, Marty I, Knollmann BC, Ackerman MJ. Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 2023;18(5):1075-1089.
Zhou W, Ye D, Tester DJ, Bains S, Giudicessi JR, Haglund-Turnquist CM, Orland KM, January CT, Eckhardt LL, Maginot KR, et al. Elucidation of as a Novel Long-QT Syndrome-Susceptibility Gene. Circ Genom Precis Med. 2023;16(2):e003726.
Stutzman MJ, Gao X, Kim M, Ye D, Zhou W, Tester DJ, Giudicessi JR, Shannon K, Ackerman MJ. Functional Characterization and Identification of a Therapeutic for a Novel SCN5A-F1760C Variant Causing Type 3 Long QT Syndrome Refractory to All Guideline-Directed Therapies. Heart Rhythm. 2023.
Pinsky AM, Gao X, Bains S, Kim CJohn, Louradour J, Odening KE, Tester DJ, Giudicessi JR, Ackerman MJ. Injectable Contraceptive, Depo-Provera, Produces Erratic Beating Patterns in Patient-Specific Induced Pluripotent Stem Cell-derived Cardiomyocytes with Type 2 Long QT Syndrome. Heart Rhythm. 2023.
Clemens DJ, Ye D, Zhou W, Kim CSJohn, Pease DR, Navaratnarajah CK, Barkhymer A, Tester DJ, Nelson TJ, Cattaneo R, et al. SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. PLoS One. 2023;18(3):e0282151.
Kim M, Sager PT, Tester DJ, Pradhananga S, Hamrick SK, Srinivasan D, Das S, Ackerman MJ. SGK1 Inhibition Attenuates the Action Potential Duration in Re-Engineered Heart Cell Models of Drug-Induced QT Prolongation. Heart Rhythm. 2023.